VanHimbergen Robert M 4

What Happened
Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., was granted 8.261 deferred stock units on May 29, 2026. The award is reported at a grant value of $23.85 per unit, totaling about $197. This was an award/grant (derivative units), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-29; Form 4 filed: 2026-06-02 (filed within the required 2-business-day window).
• Reported transaction: Grant/Award (code A) of 8.261 deferred stock units at $23.85 each; total reported value ≈ $197.
• Shares owned after the transaction: Not specified in the filing.
• Footnotes:
  • Each deferred stock unit represents the right to receive one share of company common stock or the cash equivalent (F1).
  • Deferred stock units will settle in cash or shares following termination of employment or during a specified future year per the Executive Deferral and Stock Match Plan (F2).
• This is a derivative award (deferred units), not an immediate buy or sale — no immediate cash outlay or open-market activity.

Context: Deferred stock units are compensation awards that convert to shares or cash at a later date (e.g., upon termination or at a scheduled settlement). Such grants are common executive compensation and do not by themselves indicate buying or selling sentiment.